Filing Details
- Accession Number:
- 0001179110-15-006732
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-04-28 16:34:52
- Reporting Period:
- 2015-04-24
- Filing Date:
- 2015-04-28
- Accepted Time:
- 2015-04-28 16:34:52
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 203077 | St Jude Medical Inc | STJ | Electromedical & Electrotherapeutic Apparatus (3845) | 411276891 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1402222 | S Eric Fain | One St. Jude Medical Drive St. Paul MN 55117 | Group President | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2015-04-24 | 47,000 | $40.55 | 122,585 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2015-04-24 | 45,900 | $73.83 | 76,685 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2015-04-24 | 1,100 | $74.14 | 75,585 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Options (Right to Buy) | Disposition | 2015-04-24 | 47,000 | $0.00 | 47,000 | $40.55 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2008-12-10 | 2015-12-10 | No | 4 | M | Direct |
Footnotes
- The total includes 432 additional shares acquired through the Company Employee Stock Purchase Plan on 7/31/14.
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on February 6, 2015.
- The price in Column 4 is a weighted average. The prices actually received ranged from $73.08 to $74.08. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
- The price in Column 4 is a weighted average. The prices actually received ranged from $74.09 to $74.16. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
- Fully vested at the time of filing.
Billionaire Hedge Funds
